ChemGenex Pharmaceuticals Announces Omapro to be Reviewed by the FDA`s Oncologic Drugs Advisory Committee for the Treatment of Adults with Chronic Myeloid Leukemia who have Failed Prior Therapy with Imatinib and have the Bcr